- Type / Class
- Equity / Common Stock
- Shares outstanding
- 147,079,094
- Total 13F shares
- 131,405,263
- Share change
- +2,419,400
- Total reported value
- $20,085,982,511
- Put/Call ratio
- 137%
- Price per share
- $152.92
- Number of holders
- 861
- Value change
- +$272,768,825
- Number of buys
- 361
- Number of sells
- 475
Quarterly Holders Quick Answers
What is CUSIP 09062X103?
CUSIP 09062X103 identifies BIIB - BIOGEN INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09062X103:
Top shareholders of BIIB - BIOGEN INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
16,678,507
|
$3,232,961,797 | — | 30 Sep 2024 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
11%
|
16,315,079
|
$3,162,514,912 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
10%
|
15,347,041
|
$2,974,870,411 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
5%
|
7,344,960
|
$1,423,747,046 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.6%
|
5,257,323
|
$1,019,079,489 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.5%
|
5,131,193
|
$994,630,453 | — | 30 Sep 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.9%
|
4,256,286
|
$825,039,000 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
3,613,020
|
$698,062,186 | — | 30 Sep 2024 | |
| NORGES BANK |
13F
|
Company |
1.5%
|
2,264,392
|
$438,929,745 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
1,912,546
|
$370,729,000 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
1,887,246
|
$365,824,336 | — | 30 Sep 2024 | |
| Beutel, Goodman & Co Ltd. |
13F
|
Company |
1.2%
|
1,744,154
|
$338,086,000 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.1%
|
1,629,733
|
$315,907,445 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.92%
|
1,353,135
|
$262,291,688 | — | 30 Sep 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.85%
|
1,251,953
|
$242,677,847 | — | 30 Sep 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.81%
|
1,184,456
|
$229,594,951 | — | 30 Sep 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.78%
|
1,152,691
|
$223,437,624 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.78%
|
1,150,486
|
$223,012,350 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.76%
|
1,114,340
|
$216,010,089 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.68%
|
1,003,135
|
$194,447,615 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.67%
|
989,041
|
$191,715,705 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.65%
|
952,706
|
$184,672,531 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.63%
|
921,256
|
$178,576,264 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.62%
|
913,029
|
$176,981,595 | — | 30 Sep 2024 | |
| Man Group plc |
13F
|
Company |
0.58%
|
856,835
|
$166,088,896 | — | 30 Sep 2024 | |
| Amundi |
13F
|
Individual |
0.61%
|
897,512
|
$163,616,438 | — | 30 Sep 2024 | |
| Alexander J. Denner |
3/4/5
|
Director |
—
class O/S missing
|
658,099
|
$163,208,552 | — | 15 Jun 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.55%
|
813,000
|
$157,591,920 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.49%
|
714,285
|
$138,457,006 | — | 30 Sep 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.48%
|
711,184
|
$137,855,906 | — | 30 Sep 2024 | |
| Employees Provident Fund Board |
13F
|
Company |
0.46%
|
678,080
|
$131,439,027 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.45%
|
658,151
|
$127,575,990 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.44%
|
648,702
|
$125,744,396 | — | 30 Sep 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.41%
|
601,986
|
$116,688,970 | — | 30 Sep 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.39%
|
568,510
|
$110,123,230 | — | 30 Sep 2024 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.36%
|
525,513
|
$101,865,439 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.34%
|
503,853
|
$97,666,867 | — | 30 Sep 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.32%
|
472,525
|
$91,781,398 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.3%
|
434,939
|
$84,308,576 | — | 30 Sep 2024 | |
| Swiss National Bank |
13F
|
Company |
0.29%
|
432,100
|
$83,758,264 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.29%
|
427,600
|
$82,885,984 | — | 30 Sep 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.29%
|
423,284
|
$82,049,371 | — | 30 Sep 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.28%
|
414,396
|
$80,269,092 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.28%
|
413,360
|
$80,125,702 | — | 30 Sep 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.27%
|
399,404
|
$77,420,000 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.27%
|
398,136
|
$77,174,682 | — | 30 Sep 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.27%
|
395,071
|
$76,580,563 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.26%
|
381,214
|
$73,894,576 | — | 30 Sep 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.25%
|
371,001
|
$72,222,764 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.25%
|
372,366
|
$72,179,426 | — | 30 Sep 2024 |
Institutional Holders of BIOGEN INC. - Common Stock (BIIB) as of Q4 2024
As of 31 Dec 2024,
BIOGEN INC. - Common Stock (BIIB) was held by
861 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
131,405,263 shares.
The largest 10 holders included
VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, BlackRock, Inc., STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, T. Rowe Price Investment Management, Inc., Pacer Advisors, Inc., NORGES BANK, and Invesco Ltd..
This page lists
867
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
903
Q4 2024 holders
861
Holder diff
-42
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.